ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS

Elastomeric infusion pumps, also known as disposable balloon pumps, are used to administer intravenous (IV) drugs such as local anesthetics, antibiotics, and anti-neoplastic. These non-electronic, non-gravity driven devices are used in single infusions. Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled with a drug and pressure from the elastic walls drives fluid delivery with relatively consistent pressure until it reaches near the end of the infusion.

Global elastomeric infusion pumps market is estimated to be valued at USD 1,255.4 Mn in 2024 and is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031).

Figure 1. Global Elastomeric Infusion Pumps Market Value (US$ Mn), by Region, 2024

To learn more about this report, request sample copy

Post-operative pain in surgeries such as total knee replacement and total hip replacement is usually treated by infusion of analgesics through disposable infusion pumps. Therefore, increasing number of orthopedic procedures and surgeries is expected to boost growth of the global elastomeric infusion pumps market over the forecast period.

For instance, according to a 2018 report by American Academy of Orthopedic Surgeons, over 1 million patients and over 1.4 million hip and knee arthroplasty procedures were entered into the American Joint Replacement Registry.

Figure 2. Global Elastomeric Infusion Pumps Market Share, by treatment, 2024

To learn more about this report, request sample copy

The increasing incidence of chronic blood diseases such as blood cancer is expected to drive growth of the global elastomeric infusion pumps market over the forecast period.

The increasing incidence of chronic blood diseases such as blood cancers which include leukemia, lymphoma, and myeloma or blood disorders such as anemia or bleeding disorders such as blood clots and hemophilia is expected to drive growth of the global elastomeric infusion pumps market over the forecast period.

For instance, According to the Centers for Disease Control and Prevention (CDC) in 2019, the Sickle Cell Disease (SCD) affects around 100,000 Americans each year. Moreover, according to Leukemia & Lymphoma Society, it was estimated that around 172,910 people in the U.S. were expected to be diagnosed with the leukemia, lymphoma or myeloma in 2017.

Global Elastomeric Infusion Pumps Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Elastomeric infusion pumps market faced negative impact due COVID-19 as there was lack of transportation facility of raw material used to manufacture infusion pumps.

Recent Developments

On January 4, 2024, the East and North Hertfordshire NHS Trust, an organizational entity within the National Health Services of England and Wales, announced the launch of a new elastomeric pump pathway for hospital at home patients in East and North Hertfordshire. For patients on antibiotics, the elastomeric device enables nurses to deliver medications with just one visit each day, reducing the number of nursing visits by half.

Global Elastomeric Infusion Pumps Market: Restraint

The costs of elastomeric infusion pumps keep fluctuating depending on the type of the pumps. For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high. Such scenario is expected to hinder growth of the global elastomeric infusion pumps market over the forecast period.

Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is also expected to hamper the market growth. For instance, the European Commission and the U.S. Food and Drug Administration (FDA) published safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in parts of elastomeric infusion pumps. Therefore, manufacturers need to focus on proper safety labeling of products to avoid severe side effects, especially in neonatal patient population.

Key Players

Major players operating in the global elastomeric infusion pumps market include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.